DailyDoctor Archive Specialties Get app
All nephrology briefings

The edition · Nephrology

High-dose vitamin C doubled 28-day mortality in severe burns, and correcting acidosis still did nothing for the kidneys

VICTORY was stopped early for harm, with 28-day mortality of 15.0% against 7.6%; a new histologic class identifies the fastest progressors in diabetic nephropathy; pre-filter haemodiafiltration clears middle molecules better in children but raises blood pressure; and measured GFR clears testosterone of driving age-related decline.

The edition in brief

The VICTORY trial randomised 238 adults with deep burns covering 20% or more of body surface area, across 24 burn centres on four continents, to intravenous vitamin C 50 mg/kg six-hourly for 96 hours or placebo. It was stopped at the first prespecified interim analysis for futility and harm: the composite of 28-day mortality and persistent organ dysfunction occurred in 40.8% against 29.7% (adjusted RR 1.28, 95% CI 0.99-1.65), and 28-day mortality was 15.0% against 7.6% (adjusted RR 1.96, 1.32-2.90). A reanalysis of the TRIDENT cohort of 176 patients with diabetes undergoing indicated kidney biopsy, validated in 101 more, added a Class 5 defined by visceral epithelial hyperplasia to the Renal Pathology Society classification, improving two-year prediction from an AUC of 0.71 to 0.75. In a randomised crossover trial, 21 children on maintenance dialysis achieved median convection volumes of 36.2 against 14.3 l/m2 per session on pre-filter versus post-filter haemodiafiltration, with lower alpha-1-microglobulin, beta-2-microglobulin, myoglobin and inflammatory markers, but higher diastolic blood pressure. The Renal Iohexol Clearance Survey followed 800 men aged 50-62 with iohexol-measured GFR for a median of 10.9 years and found no association between testosterone, free testosterone or sex hormone-binding globulin and the rate of GFR decline. The edition closes on SODa-BIC, in which sodium bicarbonate did not reduce major adverse kidney events in vasopressor-dependent metabolic acidosis.

In this edition
01
Clinical update

VICTORY stopped early: high-dose intravenous vitamin C doubled 28-day mortality in severe burns

Stop high-dose intravenous vitamin C in severe burns — mortality at 28 days was double that of placebo, and the trial was halted for harm.

2 min · JAMARead →
Primary outcome
composite of 28-day mortality and persistent organ dysfunction (ventilation, kidney replacement therapy or vasopressor dependence at day 28)
Effect
40.8% vs 29.7% (adjusted RR 1.28; 95% CI 0.99-1.65; P = .06); 28-day mortality 15.0% vs 7.6% (adjusted RR 1.96; 1.32-2.90; P = .001)
02Clinical update

A new histologic class separates the fastest progressors in diabetic nephropathy

Look for visceral epithelial hyperplasia on the diabetic nephropathy biopsy report; it marks the group that progresses fastest to kidney failure.

2 min · Kidney internationalRead →
03Research

Pre-filter haemodiafiltration cleared middle molecules better in children — and raised diastolic pressure

Pre-filter haemodiafiltration clears middle molecules substantially better in children, but plan for the sodium load and watch the diastolic pressure.

2 min · Kidney internationalRead →
04Research

Measured GFR clears testosterone of driving age-related kidney function decline

Testosterone is not a driver of age-related GFR decline — the earlier signal was a creatinine artefact of muscle mass.

2 min · Kidney internationalRead →
05Pearl

When the creatinine and the patient disagree, the creatinine is usually wrong

In a frail or cachectic patient, a normal creatinine can conceal substantial kidney impairment — check cystatin C before dosing a renally cleared drug.

1 minRead →
06
Practice changer

Sodium bicarbonate did not reduce major adverse kidney events in vasopressor-dependent acidosis

Stop correcting metabolic acidosis with bicarbonate in shocked patients; it did not reduce death, dialysis or persistent renal dysfunction.

2 min · The New England journal of medicineRead →
Primary outcome
major adverse kidney event (death, renal-replacement therapy or persistent renal dysfunction) within 30 days
Effect
40.2% vs 39.4% (adjusted difference 1.2 percentage points; 95% CI -7.1 to 9.4; P = 0.78); renal-replacement therapy 16.8% vs 20.9%; 30-day in-hospital mortality 25.4% vs 24.0%

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for nephrology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free